6jkj
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of human SPSB2 in the apo-state== | |
| + | <StructureSection load='6jkj' size='340' side='right'caption='[[6jkj]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[6jkj]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6JKJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6JKJ FirstGlance]. <br> | ||
| + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6jkj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6jkj OCA], [http://pdbe.org/6jkj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6jkj RCSB], [http://www.ebi.ac.uk/pdbsum/6jkj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6jkj ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/SPSB2_HUMAN SPSB2_HUMAN]] Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.<ref>PMID:15601820</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The SPRY domain-containing SOCS box protein 2 (SPSB2) is one of four mammalian SPSB proteins that are characterized by a C-terminal SOCS box and a central SPRY/B30.2 domain. SPSB2 interacts with inducible nitric oxide synthase (iNOS) via the SPRY domain and polyubiquitinates iNOS, resulting in its proteasomal degradation. Inhibitors that can disrupt SPSB2-iNOS interaction and augment NO production may serve as novel anti-infective and anticancer agents. The previously determined murine SPSB2 structure may not reflect the true apo conformation of the iNOS-binding site. Here, the crystal structure of human SPSB2 SPRY domain in the apo state is reported at a resolution of 1.9 A. Comparison of the apo and ligand-bound structures reveals that the iNOS-binding site is highly preformed and that major conformational changes do not occur upon ligand binding. Moreover, the C-terminal His6 tag of the recombinant protein binds to a shallow pocket adjacent to the iNOS-binding site on a crystallographically related SPSB2 molecule. These findings may help in structure-based and fragment-based SPSB2 inhibitor design in the future. | ||
| - | + | Crystal structure of the SPRY domain of human SPSB2 in the apo state.,Luo Y, Li K, Yang J, Zhang D, Zhou Y, Kuang Z Acta Crystallogr F Struct Biol Commun. 2019 Jun 1;75(Pt 6):412-418. doi:, 10.1107/S2053230X1900623X. Epub 2019 May 10. PMID:31204687<ref>PMID:31204687</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | [[Category: | + | <div class="pdbe-citations 6jkj" style="background-color:#fffaf0;"></div> |
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
[[Category: Kuang, Z]] | [[Category: Kuang, Z]] | ||
| + | [[Category: Luo, Y]] | ||
| + | [[Category: E3 ubiquitin ligase]] | ||
| + | [[Category: Protein binding]] | ||
| + | [[Category: Spry domain-containing socs box protein]] | ||
| + | [[Category: Spsb2]] | ||
Revision as of 05:51, 3 July 2019
Crystal structure of human SPSB2 in the apo-state
| |||||||||||
